Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Issued: 2019-2025

Historic Shares Issued for Fulcrum Therapeutics (FULC) over the last 6 years, with Sep 2025 value amounting to $64,000.

  • Fulcrum Therapeutics' Shares Issued fell 89.92% to $64,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 63.29%. This contributed to the annual value of $2.7 million for FY2024, which is 253.41% up from last year.
  • According to the latest figures from Q3 2025, Fulcrum Therapeutics' Shares Issued is $64,000, which was down 78.74% from $301,000 recorded in Q2 2025.
  • In the past 5 years, Fulcrum Therapeutics' Shares Issued ranged from a high of $2.8 million in Q2 2022 and a low of $64,000 during Q3 2025.
  • Over the past 3 years, Fulcrum Therapeutics' median Shares Issued value was $301,000 (recorded in 2025), while the average stood at $432,000.
  • The largest annual percentage gain for Fulcrum Therapeutics' Shares Issued in the last 5 years was 1,603.16% (2021), contrasted with its biggest fall of 99.64% (2021).
  • Over the past 5 years, Fulcrum Therapeutics' Shares Issued (Quarterly) stood at $969,000 in 2021, then slumped by 72.45% to $267,000 in 2022, then rose by 7.49% to $287,000 in 2023, then plummeted by 71.08% to $83,000 in 2024, then plummeted by 89.92% to $64,000 in 2025.
  • Its last three reported values are $64,000 in Q3 2025, $301,000 for Q2 2025, and $83,000 during Q4 2024.